{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:33:07Z","timestamp":1793406787578,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["Grant No. 2021YFC2500400"],"award-info":[{"award-number":["Grant No. 2021YFC2500400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Project","award":["20JCZXJC00090"],"award-info":[{"award-number":["20JCZXJC00090"]}]},{"name":"Tianjin Municipal Commission of Health and Wellness Project","award":["TJWJ2021MS008"],"award-info":[{"award-number":["TJWJ2021MS008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12072-022-10362-3","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T18:04:40Z","timestamp":1655229880000},"page":"835-845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population"],"prefix":"10.1007","volume":"16","author":[{"given":"Ya-Cong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Yan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ji","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ju","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-7681","authenticated-orcid":false,"given":"Ke-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"1","key":"10362_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"6","key":"10362_CR2","first-page":"939","volume":"9","author":"T Prasoppokakorn","year":"2021","unstructured":"Prasoppokakorn T, Pitisuttithum P, Treeprasertsuk S. Pharmacological therapeutics: current trends for metabolic dysfunction-associated fatty liver disease (MAFLD). J Clin Transl Hepatol. 2021;9(6):939\u2013946","journal-title":"J Clin Transl Hepatol"},{"issue":"11","key":"10362_CR3","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.cgh.2018.11.023","volume":"17","author":"P Le","year":"2019","unstructured":"Le P, Chaitoff A, Rothberg MB, McCullough A, Gupta NM, Alkhouri N. Population-based trends in prevalence of nonalcoholic fatty liver disease in US adults with type 2 diabetes. Clin Gastroenterol Hepatol. 2019;17(11):2377\u20132378","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10362_CR4","first-page":"972","volume":"9","author":"H Lin","year":"2021","unstructured":"Lin H, Zhang X, Li G, Wong GL, Wong VW. Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J Clin Transl Hepatol. 2021;9(6):972\u2013982","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10362_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","volume":"114","author":"Y Chang","year":"2019","unstructured":"Chang Y, Cho YK, Cho J, Jung HS, Yun KE, Ahn J, et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study. Am J Gastroenterol. 2019;114(4):620\u2013629","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10362_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2337\/dc17-1590","volume":"41","author":"SH Wild","year":"2018","unstructured":"Wild SH, Walker JJ, Morling JR, McAllister DA, Colhoun HM, Farran B, et al. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care. 2018;41(2):341\u2013347","journal-title":"Diabetes Care"},{"key":"10362_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.693507","volume":"8","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zou X, Wen X, Zhou X, Ji L. NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality?-Results from NHANES III. Front Med. 2021;8: 693507","journal-title":"Front Med"},{"issue":"6","key":"10362_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","volume":"75","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75(6):1284\u20131291","journal-title":"J Hepatol"},{"issue":"10","key":"10362_CR9","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","volume":"19","author":"VH Nguyen","year":"2021","unstructured":"Nguyen VH, Le MH, Cheung RC, Nguyen MH. Differential Clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD. Clin Gastroenterol Hepatol. 2021;19(10):2172\u201381.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10362_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jhep.2021.06.013","volume":"75","author":"X Chen","year":"2021","unstructured":"Chen X, Chen S, Pang J, Tang Y, Ling W. Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality? J Hepatol. 2021;75(4):987\u2013989","journal-title":"J Hepatol"},{"issue":"9","key":"10362_CR11","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/clinem\/dgab339","volume":"106","author":"G Semmler","year":"2021","unstructured":"Semmler G, Wernly S, Bachmayer S, Leitner I, Wernly B, Egger M, et al. Metabolic dysfunction-associated fatty liver disease (MAFLD)-rather a bystander than a driver of mortality. J Clin Endocrinol Metab. 2021;106(9):2670\u20132677","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10362_CR12","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","volume":"107","author":"X Wang","year":"2021","unstructured":"Wang X, Wu S, Yuan X, Chen S, Fu Q, Sun Y, et al. Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study. J Clin Endocrinol Metab. 2021;107(2):e745\u2013e755","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10362_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5009\/gnl210167","volume":"16","author":"JH Moon","year":"2022","unstructured":"Moon JH, Kim W, Koo BK, Cho NH. Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease. Gut Liver. 2022;16(3):433-442. https:\/\/doi.org\/10.5009\/gnl210167","journal-title":"Gut Liver"},{"issue":"2","key":"10362_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68(2):305\u2013315","journal-title":"J Hepatol"},{"issue":"21","key":"10362_CR15","first-page":"01055","volume":"S1542\u20133565","author":"Z Wang","year":"2021","unstructured":"Wang Z, Bertot LC, Jeffrey GP, Joseph J, Garas G, de Boer B, et al. Serum fibrosis tests guide prognosis in metabolic dysfunction-associated fatty liver disease patients referred from primary care. Clin Gastroenterol Hepatol. 2021;S1542\u20133565(21):01055\u201301057","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10362_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154958","volume":"128","author":"LJ Tang","year":"2021","unstructured":"Tang LJ, Ma HL, Eslam M, Wong GL, Zhu PW, Chen SD, et al. Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD. Metabolism. 2021;128: 154958","journal-title":"Metabolism"},{"issue":"5","key":"10362_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/apt.16760","volume":"55","author":"M Decraecker","year":"2022","unstructured":"Decraecker M, Dutartre D, Hiriart JB, Irles-Dep\u00e9 M, Chermak F, Foucher J, et al. Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods. Aliment Pharmacol Ther. 2022;55(5):580\u2013592","journal-title":"Aliment Pharmacol Ther"},{"key":"10362_CR18","volume-title":"Analytic and reporting guidelines: the third National Health and Nutrition Examination Survey NHANES III (1988\u201394)","author":"CDC\/NCHS","year":"1996","unstructured":"CDC\/NCHS. Analytic and reporting guidelines: the third National Health and Nutrition Examination Survey NHANES III (1988\u201394). Hyattsville: National Center for Health Statistics Centers for Disease Control and Prevention; 1996"},{"key":"10362_CR19","unstructured":"Third National Health and Nutrition Examination Survey. Hepatic\/Gallbladder Ultrasound and Hepatic Steatosis (HGUHS). Available at: https:\/\/wwwn.cdc.gov\/nchs\/Data\/Nhanes3\/34A\/HGUHS.htm. Accessed October 14, 2020."},{"key":"10362_CR20","unstructured":"National Health; and Nutrition Examination Survey (NHANES) III. Hepatic Steatosis Ultrasound Images Assessment Procedures Manual 2010. Available at: https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes3\/hepatic_steatosis_ultrasound_procedures_manual.pdf. Accessed October 15, 2020."},{"issue":"12","key":"10362_CR21","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep4.1776","volume":"5","author":"MM Pearson","year":"2021","unstructured":"Pearson MM, Kim NJ, Berry K, Moon AM, Su F, Vutien P, et al. Associations between alcohol use and liver-related outcomes in a large national cohort of patients with cirrhosis. Hepatol Commun. 2021;5(12):2080\u20132095","journal-title":"Hepatol Commun"},{"issue":"9","key":"10362_CR22","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","volume":"40","author":"S Lin","year":"2020","unstructured":"Lin S, Huang J, Wang M, Kumar R, Liu Y, Liu S, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40(9):2082\u20132089","journal-title":"Liver Int"},{"issue":"21","key":"10362_CR23","first-page":"01276","volume":"S1542\u20133565","author":"GEH Lim","year":"2021","unstructured":"Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2021;S1542\u20133565(21):01276\u201301283","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10362_CR24","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/liv.13435","volume":"37","author":"S Zelber-Sagi","year":"2017","unstructured":"Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms. Liver Int. 2017;37(7):936\u2013949","journal-title":"Liver Int"},{"issue":"12","key":"10362_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/nutrit\/nuw045","volume":"74","author":"C Schwedhelm","year":"2016","unstructured":"Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev. 2016;74(12):737\u2013748","journal-title":"Nutr Rev"},{"issue":"6","key":"10362_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10(6):330\u2013344","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"22","key":"10362_CR27","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.3390\/cancers13225735","volume":"13","author":"RK Shahid","year":"2021","unstructured":"Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers. 2021;13(22):5735","journal-title":"Cancers"},{"issue":"7","key":"10362_CR28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms18071534","volume":"18","author":"P Dongiovanni","year":"2017","unstructured":"Dongiovanni P, Valenti L. A nutrigenomic approach to non-alcoholic fatty liver disease. Int J Mol Sci. 2017;18(7):1534","journal-title":"Int J Mol Sci"},{"issue":"10046","key":"10362_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"E Di Angelantonio","year":"2016","unstructured":"Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Global BMI Mortality Collaboration, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776\u2013786","journal-title":"Lancet"},{"issue":"11\u201312","key":"10362_CR30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/apt.15015","volume":"48","author":"J Ampuero","year":"2018","unstructured":"Ampuero J, Aller R, Gallego-Dur\u00e1n R, Banales JM, Crespo J, Garc\u00eda-Monz\u00f3n C, et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther. 2018;48(11\u201312):1260\u20131270","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10362_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, H\u00e4ring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292\u2013300","journal-title":"Cell Metab"},{"issue":"10","key":"10362_CR32","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, Lee YH, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol. 2021;19(10):2138\u201347.e10","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10362_CR33","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jhep.2021.08.020","volume":"75","author":"VW Wong","year":"2021","unstructured":"Wong VW, Lazarus JV. Prognosis of MAFLD vs NAFLD and implications for a nomenclature change. J Hepatol. 2021;75(6):1267\u20131270","journal-title":"J Hepatol"},{"issue":"3","key":"10362_CR34","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u20131090","journal-title":"Hepatology"},{"issue":"5","key":"10362_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71(5):1006\u20131019","journal-title":"Gut"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10362-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T12:35:02Z","timestamp":1659530102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10362"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10362-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors (Ya\u2011Cong Zhang, Zhang\u2011Yan Lyu, Bing Ma, Li\u2011Min Li, Wei Wang, Chao Sheng, Hong\u2011Ji Dai, Yu\u2011Bei Huang,\nFang\u2011Fang Song, Feng\u2011Ju Song, Ke\u2011Xin Chen) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research"}},{"value":"The Third National Health and Nutrition Examination Survey (NHANES III) was approved by the institutional reviews board of the National Center for Health Statistics (), and written informed consent was obtained from all individual participants in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors of this manuscript have read and approved the final submitted version and are aware that they are listed as an author on this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}